Advertisement

Topics

New Three-in-One Blood Test Opens Door to Precision Medicine for Prostate Cancer

06:28 EDT 13 Jul 2017 | Lab Bulletin

Scientists have developed a three-in-one blood test that could transform treatment of advanced prostate cancer through use of precision drugs designed to target mutations in the BRCA genes.

ICRBy testing cancer DNA in the bloodstream, researchers found they could pick out which men with advanced prostate cancer were likely to benefit from treatment with exciting new drugs called PARP inhibitors.

Original Article: New Three-in-One Blood Test Opens Door to Precision Medicine for Prostate Cancer

NEXT ARTICLE

More From BioPortfolio on "New Three-in-One Blood Test Opens Door to Precision Medicine for Prostate Cancer"

Quick Search
Advertisement